‘Pay For Delay’ Drug Accords Get U.S. High Court Scrutiny

in 2012, Bloomberg, Keith Hylton, Newsmakers, School of Law
December 7th, 2012

Hylton_white_65wBloomberg
Keith Hylton, School of Law

The U.S. Supreme Court agreed to take up a multibillion-dollar fight between the drug industry and federal antitrust enforcers, a case that may determine how quickly low-price generic medicines reach the market…

View article

Comments are closed.